About 200 reports

Europe Drugs for Warts Market Report 2021

102 pages • By QY Research

Notes:Sales, means the sales volume of Drugs for WartsRevenue, means the sales value of Drugs for WartsThis report studies sales (consumption) of Drugs for Warts in Europe market, especially in Germany, UK, France, Italy, Spain and Russia, focuses on top players in these regions/countries, with sales, price, revenue...

3 920 4 900 3 136
Sep 2016

Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

100 pages • By Delve Insight

SUMMARYDelveInsight’s Report, “Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Dermatitis Report is to understand the market and pipeline...

1 600 2 000 1 280
Sep 2016

Ichthyosis Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

100 pages • By Delve Insight

SUMMARYDelveInsight’s Report, “Ichthyosis Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Ichthyosis Vulgaris Report is to understand...

1 600 2 000 1 280
Sep 2016

Acute Cutaneous Lupus Erythematosus (ACLE)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

100 pages • By Delve Insight

SUMMARYDelveInsight’s Report, “Acute Cutaneous Lupus Erythematosus (ACLE)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Acute Cutaneous Lupus...

1 600 2 000 1 280
Sep 2016

Genital Warts (Condylomata Acuminata)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

100 pages • By Delve Insight

SUMMARYDelveInsight’s Report, “Genital Warts (Condylomata Acuminata)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Genital Warts (Condylomata...

1 600 2 000 1 280
Sep 2016

Pruritus-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

100 pages • By Delve Insight

SUMMARYDelveInsight’s Report, “Pruritus-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Pruritus Report is to understand the market and pipeline...

1 600 2 000 1 280
Sep 2016

Xerosis (Dry Skin)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

100 pages • By Delve Insight

SUMMARYDelveInsight’s Report, “Xerosis (Dry Skin)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Xerosis (Dry Skin) Report is to understand...

1 600 2 000 1 280
Sep 2016

Onychomycosis (Tinea Unguium)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

100 pages • By Delve Insight

SUMMARYDelveInsight’s Report, “Onychomycosis (Tinea Unguium)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Onychomycosis (Tinea Unguium) Report...

1 600 2 000 1 280
Sep 2016

Contact Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

100 pages • By Delve Insight

SUMMARYDelveInsight’s Report, “Contact Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Contact Dermatitis Report is to understand...

1 600 2 000 1 280
Sep 2016

Cellulitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

100 pages • By Delve Insight

SUMMARYDelveInsight’s Report, “Cellulitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Cellulitis Report is to understand the market and pipeline...

1 600 2 000 1 280
Sep 2016

Atopic Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

100 pages • By Delve Insight

SUMMARYDelveInsight’s Report, “Atopic Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Atopic Dermatitis Report is to understand the...

1 600 2 000 1 280
Sep 2016

Actinic (Solar) Keratosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

100 pages • By Delve Insight

SUMMARYDelveInsight’s Report, “Actinic (Solar) Keratosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Actinic (Solar) Keratosis Report is...

1 600 2 000 1 280
Sep 2016

Acne Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

100 pages • By Delve Insight

SUMMARYDelveInsight’s Report, “Acne Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Acne Vulgaris Report is to understand the market...

1 600 2 000 1 280
Sep 2016

Chronic Urticaria Or Hives-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

100 pages • By Delve Insight

SUMMARYDelveInsight’s Report, “Chronic Urticaria Or Hives-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Chronic Urticaria Or Hives Report is...

1 600 2 000 1 280
Sep 2016

Lichen Simplex Chronicus (Neurodermatitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

100 pages • By Delve Insight

SUMMARYDelveInsight’s Report, “Lichen Simplex Chronicus (Neurodermatitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Lichen Simplex Chronicus...

1 600 2 000 1 280
Sep 2016

Plaque Psoriasis (Psoriasis Vulgaris)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

100 pages • By Delve Insight

SUMMARYDelveInsight’s Report, “Plaque Psoriasis (Psoriasis Vulgaris)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Plaque Psoriasis (Psoriasis...

1 600 2 000 1 280
Sep 2016

Eczema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

100 pages • By Delve Insight

SUMMARYDelveInsight’s Report, “Eczema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Eczema Report is to understand the market and pipeline...

1 600 2 000 1 280
Sep 2016

Angioedema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

100 pages • By Delve Insight

SUMMARYDelveInsight’s Report, “Angioedema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Angioedema Report is to understand the market and pipeline...

1 600 2 000 1 280
Sep 2016

Hereditary Angioedema (HAE)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

100 pages • By Delve Insight

SUMMARYDelveInsight’s Report, “Hereditary Angioedema (HAE)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hereditary Angioedema (HAE) Report...

1 600 2 000 1 280
Sep 2016

Chronic Plaque Psoriasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

100 pages • By Delve Insight

SUMMARYDelveInsight’s Report, “Chronic Plaque Psoriasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Chronic Plaque Psoriasis Report is to...

1 600 2 000 1 280
Sep 2016

Global Atopic Dermatitis Market DataPack (2016-2020)

70 pages • By Koncept Analytics

The Industry DataPack provides a unique mix of market information, analysis and estimates based on quantitative and qualitative research. The market figures and industry dynamics are given in order to determine the overall market potential and help the client in gaining a stronger foothold in the marketplace. It presents a...

360 450 288
Sep 2016

2016 Global Blister Machine Industry Market Report

150 pages • By Prof Research

The 'Global and Chinese Blister Machine Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Blister Machine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Blister Machine manufacturers and is a valuable source of guidance...

2 240 2 800 1 792
Aug 2016

Global Drugs for Warts Sales Market Report 2021

112 pages • By QY Research

Notes:Sales, means the sales volume of Drugs for WartsRevenue, means the sales value of Drugs for WartsThis report studies sales (consumption) of Drugs for Warts in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price,...

3 200 4 000 2 560
Aug 2016

Global Anti Acne Cosmetics Market Professional Survey Report 2016

119 pages • By QY Research

Notes:Production, means the output of Anti Acne CosmeticsRevenue, means the sales value of Anti Acne CosmeticsThis report studies Anti Acne Cosmetics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from...

2 800 3 500 2 240
Aug 2016

Global Drugs for Warts Market Professional Survey Report 2016

114 pages • By QY Research

Notes:Production, means the output of Drugs for WartsRevenue, means the sales value of Drugs for WartsThis report studies Drugs for Warts in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015,...

2 800 3 500 2 240
Aug 2016

Chronic Urticaria Or Hives-Pipeline Insights, 2016

60 pages • By Delve Insight

SUMMARYDelveInsight’s, “ Chronic Urticaria Or Hives-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Chronic Urticaria Or Hives. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical,...

1 000 1 250 800
Aug 2016

Hirsutism-Pipeline Insights, 2016

60 pages • By Delve Insight

SUMMARYDelveInsight’s, “ Hirsutism-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Hirsutism. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III...

1 000 1 250 800
Aug 2016

Angioedema-Pipeline Insights, 2016

60 pages • By Delve Insight

SUMMARYDelveInsight’s, “ Angioedema-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Angioedema. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase...

1 000 1 250 800
Aug 2016

Contact Dermatitis-Pipeline Insights, 2016

60 pages • By Delve Insight

SUMMARYDelveInsight’s, “ Contact Dermatitis-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Contact Dermatitis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I,...

1 000 1 250 800
Aug 2016

Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE)-Pipeline Insights, 2016

60 pages • By Delve Insight

SUMMARYDelveInsight’s, “ Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE)-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE). The DelveInsight’sReport...

1 000 1 250 800
Aug 2016